A detailed history of Members Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Members Trust CO holds 1,655 shares of AMGN stock, worth $487,447. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,655
Previous 1,550 6.77%
Holding current value
$487,447
Previous $484,000 10.12%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $32,484 - $35,424
105 Added 6.77%
1,655 $533,000
Q2 2024

Jul 29, 2024

SELL
$262.75 - $319.31 $6,568 - $7,982
-25 Reduced 1.59%
1,550 $484,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $23,929 - $28,885
89 Added 5.99%
1,575 $447,000
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $318,405 - $376,507
1,486 New
1,486 $329,000
Q3 2022

Nov 07, 2022

BUY
$224.46 - $253.15 $22,446 - $25,315
100 Added 5.87%
1,803 $406,000
Q2 2022

Aug 03, 2022

SELL
$230.71 - $256.74 $30,915 - $34,403
-134 Reduced 7.29%
1,703 $414,000
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $389,939 - $456,861
-1,837 Reduced 50.0%
1,837 $395,000
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $398,643 - $467,058
1,878 Added 104.57%
3,674 $781,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $10,277 - $11,402
-44 Reduced 2.39%
1,796 $438,000
Q1 2021

May 26, 2021

SELL
$221.91 - $258.6 $25,519 - $29,739
-115 Reduced 5.88%
1,840 $458,000
Q4 2020

Jan 25, 2021

BUY
$216.38 - $257.67 $2,812 - $3,349
13 Added 0.67%
1,955 $449,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $19,710 - $21,919
84 Added 4.52%
1,942 $494,000
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $8,308 - $10,195
42 Added 2.31%
1,858 $438,000
Q1 2018

May 22, 2018

BUY
$169.43 - $198.0 $15,587 - $18,216
92 Added 5.34%
1,816 $310,000
Q2 2017

Aug 07, 2017

BUY
N/A
1,724
1,724 $297,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Members Trust CO Portfolio

Follow Members Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Members Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Members Trust CO with notifications on news.